Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Working in Tandem: Effective Security for Weight-loss Drug Packaging
Navigating Global CDMO Trends
Anti-Counterfeiting Technology
Making the Most of Real-World Data in Clinical Trials
Inflation Reduction Act and the Impact on Biosimilars
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies
Evox Therapeutics Taps Dr. Per Lundin as CEO
Ono Pharmaceutical to Acquire Deciphera for $2.4B
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
Alentis Names Dr. Alberto Toso as Chief Scientific Officer
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies
Lonza Introduces AI-Enabled Route Scouting Service
[WEBINAR] Mitigating Supply Chain Risks in an Age of Disruption
Multiply Labs and GenScript Partner to Automate Cell Isolation
FibroBiologics Discusses Opportunities to Work with Charles River
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
[WEBINAR] Mitigating Supply Chain Risks in an Age of Disruption
Tower Cold Chain Introduces KTEvolution 12 Containers
Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Evox Therapeutics Taps Dr. Per Lundin as CEO
Ono Pharmaceutical to Acquire Deciphera for $2.4B
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
Alentis Names Dr. Alberto Toso as Chief Scientific Officer
BMS, Repertoire Immune Medicines Enter Strategic Autoimmune Vax Pact
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Anti-Counterfeiting Technology
Do You Know Your Product's Impurity Profile?
Inflation Reduction Act and the Impact on Biosimilars
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
SUANFARMA CDMO
Abzena
Syngene International Ltd.
Lannett CDMO
CMC Pharmaceuticals
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
SUANFARMA CDMO
Abzena
Syngene International Ltd.
Lannett CDMO
CMC Pharmaceuticals
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Breaking News
All
Drug Discovery and Development
Contract Manufacturing
Packaging
Compliance
Breaking News
|
Collaborations & Alliances
|
Scale-up/Technology Transfer
Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies
Will advance the development of Oncotelic’s necroptosis cancer therapy assets.
04.29.24
Breaking News
|
Drug Development
|
Promotions & Moves
Evox Therapeutics Taps Dr. Per Lundin as CEO
Lundin has 15+ years’ experience founding, leading and advising biotech companies, including co-founding Evox in 2016.
04.29.24
Breaking News
|
Drug Discovery
|
Industry News
|
R&D
Ono Pharmaceutical to Acquire Deciphera for $2.4B
Will enable ONO to build a robust presence in oncology, one of its key priority areas.
04.29.24
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
Information Technology
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.
04.29.24
Bio News
|
Breaking News
|
Drug Development
|
Promotions & Moves
Alentis Names Dr. Alberto Toso as Chief Scientific Officer
Toso has more than 10 years of drug development experience in small and large molecules for immune oncology (IO) and targeted therapies.
04.29.24
Breaking News
|
Industry News
U.S. Court Vacates Modified Consent Decree Imposed on Xellia’s Cleveland Facility
Since entering the Decree in 2016, Xellia’s site has been regularly inspected by the FDA to determine compliance with rules and regulations.
04.29.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
BMS, Repertoire Immune Medicines Enter Strategic Autoimmune Vax Pact
Leverages Repertoire's DECODE platform to develop T cell targeted immune medicines.
04.29.24
APIs
|
Breaking News
Lonza Introduces AI-Enabled Route Scouting Service
Streamlines synthetic route identification for novel APIs by combining Lonza’s supply chain intelligence and expertise with AI technology.
04.29.24
Breaking News
|
Promotions & Moves
Hypha Labs Names Chief Science Officer
Taps experienced exec with expertise in new markets and the cannabis industry.
04.29.24
Breaking News
|
Industry News
BMS 1Q: Opdivo Sales Down 10%, Announces Restructuring Initiative
Strategic Productivity Initiative aimed at $1.5 billion in cost savings includes laying off more than 2,200 employees.
04.26.24
Breaking News
|
Industry News
Pfizer’s BEQVEZ Approved by FDA for Treatment of Adults with Hemophilia B
One-time treatment is designed to enable people living with hemophilia B to produce FIX themselves.
04.26.24
Bioassay Development
|
Biologics, Proteins, Vaccines
|
Breaking News
Abzena Introduces Enhanced Bioassay Platform
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
04.26.24
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
Fujifilm & Predictive Oncology Tackle Protein Interference
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
04.25.24
Breaking News
|
Drug Development
Regeneron & Mammoth Partner on CRISPR Therapies
Aim to create disease-modifying medicines that can be delivered to tissues beyond the liver, to which most gene editing treatments are currently limited.
04.25.24
Breaking News
|
Trials & Filings
FDA Approves Utility Therapeutics’ Pivya in UTIs
Clinical trial shows 62% of the 137 subjects achieved the composite response compared to 10% who received placebo.
04.25.24
Breaking News
|
Promotions & Moves
Actym Therapeutics Taps Industry Veteran as CEO
Thomas Smart boasts a 25-year career as a biotech executive.
04.25.24
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
Multiply Labs and GenScript Partner to Automate Cell Isolation
Will introduce a fully automated solution for bead-based cell isolation.
04.25.24
Breaking News
|
Clinical Trials
|
CRO News
|
Information Technology
Parexel, Palantir Expand AI Alliance
Aims to accelerate clinical data delivery and power clinical outcomes.
04.25.24
Breaking News
|
Drug Development
|
Promotions & Moves
Ascend Taps Scott Law as COO
Law brings more than 30 years of global pharmaceutical experience.
04.25.24
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
|
Scale-up/Technology Transfer
FibroBiologics Discusses Opportunities to Work with Charles River
Anticipates a master services agreement for the development and manufacture of FibroBiologics’ fibroblast-based spheroid.
04.25.24
Breaking News
Mosaic ImmunoEngineering to Acquire the Rights to Oncotelic’s Clinical-Stage Cancer Therapies
Evox Therapeutics Taps Dr. Per Lundin as CEO
Ono Pharmaceutical to Acquire Deciphera for $2.4B
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
Alentis Names Dr. Alberto Toso as Chief Scientific Officer
View Breaking News >
CURRENT ISSUE
April 2024
Anti-Counterfeiting Technology
Navigating Global CDMO Trends
Weight-loss Drug Packaging
Clinical Supply CDMOs
Industry Experts Weigh in on Oral Solid Dosage
Newsmakers Q&A: Almac Group
Economical Mobile Workstations for Lower-Grade Cleanrooms
Pharmaceutical Manufacturing Equipment & Trends
Insight Into Obesity-Related Clinical Research
Inflation Reduction Act and the Impact on Biosimilars
View More >